{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:39Z","timestamp":1791357339682,"version":"4.3.1"},"reference-count":50,"publisher":"Cambridge University Press (CUP)","issue":"S1","license":[{"start":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T00:00:00Z","timestamp":1483401600000},"content-version":"unspecified","delay-in-days":33,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>Our knowledge and understanding of the underlying neurobiology and symptomatic expression of ADHD has advanced dramatically over the past decade. Associated with these advances has been a similar explosion of new treatment options to individualize treatment for our patients.<\/jats:p><jats:p>This article will:<jats:list list-type=\"bullet\"><jats:list-item><jats:label>\u2219<\/jats:label><jats:p>review strategies to measure ADHD symptoms and functional difficulties while seeking to achieve full symptomatic remission throughout the day<\/jats:p><\/jats:list-item><jats:list-item><jats:label>\u2219<\/jats:label><jats:p>summarize recent findings regarding the management and prioritization of ADHD and comorbid conditions and<\/jats:p><\/jats:list-item><jats:list-item><jats:label>\u2219<\/jats:label><jats:p>discuss the various pharmacologic treatment options with a focus on recently developed molecules and novel delivery systems<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1017\/s1092852916000808","type":"journal-article","created":{"date-parts":[[2017,1,3]],"date-time":"2017-01-03T07:34:11Z","timestamp":1483428851000},"page":"45-59","source":"Crossref","is-referenced-by-count":13,"title":["Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems"],"prefix":"10.1017","volume":"21","author":[{"given":"Gregory W.","family":"Mattingly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2017,1,3]]},"reference":[{"key":"S1092852916000808_ref30","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1012481"},{"key":"S1092852916000808_ref11","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4402-13.2014"},{"key":"S1092852916000808_ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200106000-00016"},{"key":"S1092852916000808_ref13","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.716"},{"key":"S1092852916000808_ref50","doi-asserted-by":"crossref","unstructured":"Robb AS , Findling RL , Childress AC , Berry SA , Belden HW , Wigal SB . Efficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHD. J Atten Disord. In press. DOI: 10.1177\/1087054714533191.","DOI":"10.1177\/1087054714533191"},{"key":"S1092852916000808_ref39","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2013.840417"},{"key":"S1092852916000808_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2014.08.001"},{"key":"S1092852916000808_ref12","volume-title":"ADHD in Adults: What the Science Says","author":"Barkley","year":"2010"},{"key":"S1092852916000808_ref7","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"S1092852916000808_ref43","first-page":"192","article-title":"A review of the pharmacological management of attention-deficit\/hyperactivity disorder","volume":"21","author":"Briars","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"S1092852916000808_ref27","first-page":"218","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"S1092852916000808_ref36","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579400003114"},{"key":"S1092852916000808_ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105058776"},{"key":"S1092852916000808_ref20","volume-title":"Behavior Rating Inventory of Executive Function \u2013 Self Report version","author":"Guy","year":"2004"},{"key":"S1092852916000808_ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707741104"},{"key":"S1092852916000808_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2013.09.036"},{"key":"S1092852916000808_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2009.12.004"},{"key":"S1092852916000808_ref16","volume-title":"ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation","author":"DuPaul","year":"1998"},{"key":"S1092852916000808_ref1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.5.816"},{"key":"S1092852916000808_ref46","doi-asserted-by":"crossref","unstructured":"Goodman DW , Starr HL , Ma YW , Rostain AL , Ascher S , Armstrong RB . Randomized, 6-week, placebo-controlled study of treatment for adult attention-deficit\/hyperactivity disorder: individualized dosing of osmotic-release oral system (OROS) methylphenidate with a goal of symptom remission journal of clinical psychiatry. In press. DOI: 10.4088\/JCP.15m10348.","DOI":"10.4088\/JCP.15m10348"},{"key":"S1092852916000808_ref25","doi-asserted-by":"publisher","DOI":"10.1177\/108705470000300403"},{"key":"S1092852916000808_ref23","doi-asserted-by":"crossref","unstructured":"Faraone SV , Childress A , Wigal SB , et al Reliability and validity of the Daily Parent Rating of Evening and Morning Behavior Scale. J Atten Disord. In press. DOI: 10.1177\/1087054715619009.","DOI":"10.1177\/1087054715619009"},{"key":"S1092852916000808_ref32","unstructured":"Mattingly G , Childress A , Nordbrock E , Adej A , Kupper RJ , Weiss M . Clinical response and symptomatic remission with Aptensio XR (methylphenidate extended realease) in children and adolescents with ADHD. Poster. Presented at: American Psychiatry Association Meeting; May 14\u201318, 2016; Atlanta, GA."},{"key":"S1092852916000808_ref48","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0120"},{"key":"S1092852916000808_ref22","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05779pur"},{"key":"S1092852916000808_ref24","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04902pur"},{"key":"S1092852916000808_ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1087054705286049"},{"key":"S1092852916000808_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2004.11.001"},{"key":"S1092852916000808_ref47","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900027541"},{"key":"S1092852916000808_ref45","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0100"},{"key":"S1092852916000808_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.11.006"},{"key":"S1092852916000808_ref19","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2008.09.1904"},{"key":"S1092852916000808_ref15","first-page":"47","article-title":"Reliability and validity of the SKAMP rating scale in a laboratory school setting","volume":"34","author":"Wigal","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"S1092852916000808_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00271-0"},{"key":"S1092852916000808_ref35","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852912000235"},{"key":"S1092852916000808_ref3","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0903"},{"key":"S1092852916000808_ref44","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2016.1147558"},{"key":"S1092852916000808_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.97"},{"key":"S1092852916000808_ref17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-4450"},{"key":"S1092852916000808_ref28","first-page":"44","article-title":"Interpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of lisdexamfetamine dimesylate in ADHD","volume":"17","author":"Goodman","year":"2010","journal-title":"Primary Psychiatry"},{"key":"S1092852916000808_ref33","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0160"},{"key":"S1092852916000808_ref40","doi-asserted-by":"publisher","DOI":"10.1089\/10445460252943533"},{"key":"S1092852916000808_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2007.00430.x"},{"key":"S1092852916000808_ref49","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1216716"},{"key":"S1092852916000808_ref42","doi-asserted-by":"crossref","unstructured":"Chen MH , Pan TL , Hsu JW , et al Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: a nationwide longitudinal study. Eur Neuropsychopharmacol. In press. DOI: 10.1016\/j.euroneuro.2016.09.369.","DOI":"10.1016\/j.euroneuro.2016.09.369"},{"key":"S1092852916000808_ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10802-005-9008-5"},{"key":"S1092852916000808_ref31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-39"},{"key":"S1092852916000808_ref18","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2749"},{"key":"S1092852916000808_ref38","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1176\/ajp.151.11.1673","article-title":"DSM-IV field trials for oppositional defiant disorder and conduct disorder in children and adolescents","volume":"151","author":"Lahey","year":"1994","journal-title":"Am J Psychiatry"},{"key":"S1092852916000808_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61684-6"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852916000808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T16:28:59Z","timestamp":1555604939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852916000808\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":50,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1092852916000808"],"URL":"https:\/\/doi.org\/10.1017\/s1092852916000808","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}